{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:43:00Z","timestamp":1782783780143,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81860327"],"award-info":[{"award-number":["81860327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82160677"],"award-info":[{"award-number":["82160677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Plan of Jiangxi Provincial Health and Family Planning Commission","award":["20175521"],"award-info":[{"award-number":["20175521"]}]},{"name":"Science and Technology Research Project of Jiangxi Provincial Department of Education","award":["GJJ150061"],"award-info":[{"award-number":["GJJ150061"]}]},{"name":"The 5511 Talent Planning of Jiangxi Province","award":["20165BCB18002"],"award-info":[{"award-number":["20165BCB18002"]}]},{"name":"Key Innovation Project of Jiangxi Province","award":["20171ACG70007"],"award-info":[{"award-number":["20171ACG70007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95464-2","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T10:39:58Z","timestamp":1743503998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Design and bioactivity evaluation of a novel autotaxin inhibitor with anti-hepatic fibrosis effects"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuzheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueteng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"1","key":"95464_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbalip.2012.07.019","volume":"1831","author":"I Sevastou","year":"2013","unstructured":"Sevastou, I. et al. Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)\/LPC and ATX\/LPA axes. Biochim. Biophys. Acta1831(1), 42\u201360 (2013).","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"95464_CR2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.28973","volume":"65","author":"E Kaffe","year":"2017","unstructured":"Kaffe, E. et al. Hepatocyte autotaxin expression promotes liver fibrosis and cancer. Hepatology 65(4), 1369\u20131383 (2017).","journal-title":"Hepatology"},{"issue":"7","key":"95464_CR3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/13543776.2017.1323331","volume":"27","author":"A Nikolaou","year":"2017","unstructured":"Nikolaou, A. et al. Autotaxin inhibitors: A patent review (2012\u20132016). Expert Opin. Ther. Pat. 27(7), 815\u2013829 (2017).","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"95464_CR4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","volume":"6","author":"TM Maher","year":"2018","unstructured":"Maher, T. M. et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): A phase 2a randomised placebo-controlled trial. Lancet Respir. Med. 6 (8), 627\u2013635 (2018).","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"95464_CR5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.21873\/anticanres.16908","volume":"44","author":"JS Kim","year":"2024","unstructured":"Kim, J. S. et al. BBT-877, a novel autotaxin inhibitor, abrogates drug resistance in epithelial ovarian cancer stem cells. Anticancer Res. 44(3), 1131\u20131142 (2024).","journal-title":"Anticancer Res."},{"issue":"2","key":"95464_CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13543784.2024.2305126","volume":"33","author":"J Simonetti","year":"2024","unstructured":"Simonetti, J. et al. Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis. Expert Opin. Investig. Drugs 33(2), 133\u2013143 (2024).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"95464_CR7","doi-asserted-by":"crossref","unstructured":"Loganathan, L. et al. Computational and pharmacogenomics insights on hypertension treatment: Rational drug design and optimization strategies. Curr. Drug Targets  (2019).","DOI":"10.2174\/1389450120666190808101356"},{"issue":"3","key":"95464_CR8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11596-019-2042-2","volume":"39","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. Rational design of hybrid peptides: A novel drug design approach. Curr. Med. Sci. 39(3), 349\u2013355 (2019).","journal-title":"Curr. Med. Sci."},{"key":"95464_CR9","unstructured":"Kim, E. & Kim, C. Rational drug design approach of receptor tyrosine kinase type III inhibitors. Curr. Med. Chem. (2018)."},{"key":"95464_CR10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.csbj.2019.02.006","volume":"17","author":"S Pal","year":"2019","unstructured":"Pal, S. et al. Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors. Comput. Struct. Biotechnol. J. 17, 291\u2013310 (2019).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"95464_CR11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.compbiolchem.2019.02.001","volume":"79","author":"T Mostashari-Rad","year":"2019","unstructured":"Mostashari-Rad, T., Saghaei, L. & Fassihi, A. Gp41 inhibitory activity prediction of theaflavin derivatives using ligand\/structure-based virtual screening approaches. Comput. Biol. Chem. 79, 119\u2013126 (2019).","journal-title":"Comput. Biol. Chem."},{"key":"95464_CR12","unstructured":"!!! INVALID CITATION !!!."},{"issue":"8","key":"95464_CR13","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1021\/ci900133j","volume":"49","author":"P Baldi","year":"2009","unstructured":"Baldi, P. & Hirschberg, D. S. An intersection inequality sharper than the Tanimoto triangle inequality for efficiently searching large databases. J. Chem. Inf. Model. 49(8), 1866\u20131870 (2009).","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"95464_CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/ci990316u","volume":"40","author":"JW Godden","year":"2000","unstructured":"Godden, J. W., Xue, L. & Bajorath, J. Combinatorial preferences affect molecular similarity\/diversity calculations using binary fingerprints and Tanimoto coefficients. J. Chem. Inf. Comput. Sci. 40(1), 163\u2013166 (2000).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"95464_CR15","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. EKF-GPR-Based fingerprint renovation for subset-based indoor localization with adjusted cosine similarity. Sensor (Basel) 18(1) (2018).","DOI":"10.3390\/s18010318"},{"issue":"1\u20133","key":"95464_CR16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.forsciint.2010.10.013","volume":"208","author":"IE Dror","year":"2011","unstructured":"Dror, I. E. et al. Cognitive issues in fingerprint analysis: inter- and intra-expert consistency and the effect of a \u2018target\u2019 comparison. Forensic Sci. Int. 208(1\u20133), 10\u201317 (2011).","journal-title":"Forensic Sci. Int."},{"issue":"9","key":"95464_CR17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10822-009-9285-0","volume":"23","author":"SM Arif","year":"2009","unstructured":"Arif, S. M., Holliday, J. D. & Willett, P. Analysis and use of fragment-occurrence data in similarity-based virtual screening. J. Comput. Aided Mol. Des. 23(9), 655\u2013668 (2009).","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"4","key":"95464_CR18","doi-asserted-by":"crossref","first-page":"e0195478","DOI":"10.1371\/journal.pone.0195478","volume":"13","author":"K Pasupa","year":"2018","unstructured":"Pasupa, K. & Kudisthalert, W. Virtual screening by a new Clustering-based weighted similarity extreme learning machine approach. PLoS One 13(4), e0195478 (2018).","journal-title":"PLoS One"},{"issue":"12","key":"95464_CR19","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1021\/ci400429g","volume":"53","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. An integrated virtual screening approach for VEGFR-2 inhibitors. J. Chem. Inf. Model. 53(12), 3163\u20133177 (2013).","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"95464_CR20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/ci2001583","volume":"51","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. P-glycoprotein substrate models using support vector machines based on a comprehensive data set. J. Chem. Inf. Model. 51(6), 1447\u20131456 (2011).","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"95464_CR21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1248\/cpb.55.44","volume":"55","author":"PM Sivakumar","year":"2007","unstructured":"Sivakumar, P. M., Geetha Babu, S. K. & Mukesh, D. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method. Chem. Pharm. Bull. (Tokyo)  55(1), 44\u201349 (2007).","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"1","key":"95464_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1359-6446(02)02556-4","volume":"8","author":"CA Lipinski","year":"2003","unstructured":"Lipinski, C. A. Chris Lipinski discusses life and chemistry after the rule of five. Drug Discov Today 8(1), 12\u201316 (2003).","journal-title":"Drug Discov Today"},{"key":"95464_CR23","doi-asserted-by":"crossref","unstructured":"Wu, Z. et al. ADMET evaluation in drug discovery. 19. Reliable prediction of human cytochrome P450 inhibition using artificial intelligence approaches. J. Chem. Inf. Model.  (2019).","DOI":"10.1021\/acs.jcim.9b00801"},{"key":"95464_CR24","doi-asserted-by":"crossref","first-page":"107124","DOI":"10.1016\/j.compbiolchem.2019.107124","volume":"83","author":"P Bansode","year":"2019","unstructured":"Bansode, P. et al. Evaluation of drug candidature: in Silico ADMET, binding interactions with CDK7 and normal cell line studies of potentially anti-breast cancer enamidines. Comput. Biol. Chem. 83, 107124 (2019).","journal-title":"Comput. Biol. Chem."},{"key":"95464_CR25","doi-asserted-by":"crossref","unstructured":"Kalirajan, R. et al. In-silico design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer. Curr. Drug Res. Rev., (2019).","DOI":"10.2174\/2589977511666190912154817"},{"issue":"1","key":"95464_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13065-019-0556-0","volume":"13","author":"R Kataria","year":"2019","unstructured":"Kataria, R. & Khatkar, A. In-silico design, synthesis, ADMET studies and biological evaluation of novel derivatives of chlorogenic acid against urease protein and H. Pylori bacterium. BMC Chem. 13(1), 41 (2019).","journal-title":"BMC Chem."},{"issue":"5","key":"95464_CR27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.pharep.2019.04.006","volume":"71","author":"S Sahu","year":"2019","unstructured":"Sahu, S. et al. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor. Pharmacol. Rep. 71(5), 762\u2013767 (2019).","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"95464_CR28","doi-asserted-by":"crossref","first-page":"e1800387","DOI":"10.1002\/ardp.201800387","volume":"352","author":"AA El-Helby","year":"2019","unstructured":"El-Helby, A. A. et al. Design, synthesis, in silico ADMET profile and GABA-A Docking of novel phthalazines as potent anticonvulsants. Arch. Pharm. (Weinheim)  352(5), e1800387 (2019).","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"8","key":"95464_CR29","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1021\/acs.jmedchem.8b00232","volume":"61","author":"A Nikolaou","year":"2018","unstructured":"Nikolaou, A. et al. Hydroxamic acids constitute a novel class of autotaxin inhibitors that exhibit in vivo efficacy in a pulmonary fibrosis model. J. Med. Chem. 61(8), 3697\u20133711 (2018).","journal-title":"J. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95464-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:26:33Z","timestamp":1743740793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95464-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95464"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95464-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11092"}}